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Department ofBiological Chemistry, and The Mental Retardation Research Center, UCLA School of Medicine, 
Los Angeles, California 90024 
Abstract. A simple adhesion assay was used to mea- 
sure the interaction between rat oligodendrocytes and 
various substrata, including a matrix secreted by glial 
cells. Oligodendrocytes bound to surfaces coated with 
fibronectin, vitronectin and a protein component of the 
glial matrix. The binding of cells to all of these sub- 
strates was inhibited by a synthetic peptide (GRGDSP) 
modeled after the cell-binding domain of fibronectin. 
The component of the glial matrix responsible for the 
oligodendrocyte interaction is a protein which is either 
secreted by the glial cells or removed from serum by 
products of these cultures; serum alone does not pro- 
mote adhesion to the same extent as the glial-derived 
matrix. The interaction of cells with this glial-derived 
matrix requires divalent cations and is not mediated by 
several known RGD-containing extracellular proteins, 
including fibronectin, vitronectin, thrombospondin, 
type I and type IV collagen, and tenascin. 
T 
HE surface interactions ofcells with neighboring cells 
and, in some cases, with the extracellular matrix are 
among the most critical determinants of form and 
function in a developing tissue. The mechanisms of cell 
adhesion and the biochemistry of numerous components of
extracellular matrix and of basement membrane implicated 
in these adhesive interactions is being actively examined (13, 
18, 38, 41, 42, 49). Among noncollagenous proteins with 
cell-binding functions, fibronectin has been the most thor- 
oughly characterized (16, 49). Specific-binding domains for 
various extracellular ligands have been mapped within the 
molecule, including adomain implicated in cell binding. Ac- 
tivity within the cell-binding domain has been further local- 
ized to a tripeptide of arginine-glycine-aspartic ac d(RGD 
in single letter code) (31, 32, 51). When immobilized on a 
surface, synthetic peptides which contain the RGD sequence 
mimic fibronectin's cell-binding properties. When presented 
in solution, these same peptides competitively inhibit the 
binding of fibronectin to its cell surface receptor. 
The mechanism defined for binding of cells to fibronectin 
appears to be of general significance. The RGD sequence has 
been found in the primary sequence of at least five other ex- 
tracellular proteins with cell-binding functions, suggesting 
the existence of a family of proteins which bind cells via a 
common mechanism (40, 41). RGD-dependent interactions 
have been described in Dictyostelium (10), Drosophila (28), 
and Xenopus (3) as well as in mammalian and avian cells 
(40), suggesting that the interactions are highly conserved 
across species boundaries. Studies with synthetic ompeti- 
tors will be useful in discovering new functional members of 
the RGD-family of proteins even before direct purification 
and sequence data confirms their existence. 
The importance ofcell surface interactions intissue devel- 
opment is probably commensurate with the complexity of 
the organ, therefore, these interactions would seem to play 
a crucial role in developing brain. Of the many biosynthetic 
events which take place in brain development, one of the 
most dramatic is myelination ofneuronal axons by oligoden- 
drocytes. Since the brain contains many process-bearing 
cells, including some neurons, which are not myelinated, 
specific recognition and adhesion events between certain 
neurons and oligodendroglia are likely to be critical in deter- 
mining the ability of oligodendrocytes o form a stable my- 
elin sheath. 
We and others have shown that highly purified cultured 
oligodendrocytes produce a myelin-like membrane that is 
strikingly similar in morphology and biochemistry to the 
sheath seen in vivo (4, 39, 46). Unlike myelin-forming cells 
of the peripheral nervous ystem (Schwann cells), cultures of 
oligodendrocytes will produce a myelin-like membrane in
the absence of neurons and are, therefore, ideally suited for 
experiments on the control of myelinogenesis. In this study, 
we have examined oligodendrocyte adhesion to various ur- 
faces with the long term aim of assessing the contribution of 
these interactions tooligodendrocyte maturation and to the 
development of the cell's myelin-like properties. We have 
also examined the possibility that an RGD-dependent inter- 
action might be an early step in the sequence of events lead- 
ing to formation of the myelin sheath (5). 
Materials and Methods 
Polystyrene 24-well plates, not issue culture treated, were manufactured by 
Linbro and obtained from Flow Laboratories (McClean, VA). Calf serum 
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was obtained from Hyclone (Logan, UT). The Labline Junior Orbit orbital 
shaker used in both cell culture and adhesion assays was purchased from 
American Scientific Products (McGaw Park, IL). [35S]Translabel was pur- 
chased from ICN (Cleveland, OH). Bovine plasma was purchased from Ir- 
vine Scientific (Santa Ana, CA). Rat fibronectin was purchased from Cal- 
biochem (La Jolla, CA). Human vitronectin and rabbit antibodies to human 
vitronectin were a gift of Dr. Erkki Ruoslahti of the La Jolla Cancer Re- 
search Foundation (La Jolla, CA). Antibodies to mouse fibronectin were the 
gift of Dr. Judy Berliner of the Department ofAnatomy, UCLA. Antibodies 
to human thrombospondin were a gift of Dr. David Roberts of the National 
Institutes of Health (NIH, Bethesda, MD). Antibodies to glial fibriliary 
acidic protein were the gift of Dr. L. Eng of the V.A. Medical Center (Palo 
Alto, CA). Antibodies to rat type IV collagen were a gift of Dr. John Fessler 
of the Department of Biology, UCLA. Antibodies to chick tenascin were 
a gift of Dr. Douglas Fambrough of the Department ofBiology, Johns Hop- 
kins University (Baltimore, MD). Preparation of antibodies to galacto- 
cerebroside have been described elsewhere (39). All other chemicals were 
from standard commercial suppliers. 
Methods 
Cell Culture. Purified oligodendrocytes were prepared from neonatal rat 
cerebral cortex by a modification of the method of McCarthy and de Vellis 
(25), as described (39). This method is based on the differential dhesion 
of oligodendroeytes and astrocytes in mixed glial cultures. Oligodendrocytes 
are released into the culture medium upon extended shaking, while astro- 
cytes remain attached to the plastic surface. 
Astroglial Matrix l~reparation. Media was removed from confluent 
mixed glial cells and 1 ml water per well or 10 ml per 75 cm 2 flask was 
added. After 2 h at room temperature the plates or flasks were swirled 
briefly and the lysed cell material removed. The surfaces were washed two 
times with PBS and then stored in PBS at 37"C until use. Surfaces treated 
in this way contained no microscopically detectable c ll debris or membra- 
nous structures. The material remaining on the culture surface after water 
lysis and wash is referred to as the astroglial matrix (AGM) ~. A typical 
AGM preparation contained 0.75-1.0 ~tg protein/cm 2 of culture surface. 
AGM was removed from the plastic surface for analysis by sohibilization 
in 62.5 mM "Iris, pH 6.8, containing 3 % SDS, 10% glycerol, and 5 % [~-mer- 
captoethanol for 1 h at room temperature. 
Adhesion Assay. Oligodendrocytes r leased into the media upon shaking 
mixed glial cultures (39) were collected by centrifugation in a clinical cen- 
trifuge. The cell pellet was suspended by trituration i  10 ml of methionine- 
and glutamine-free Modified Eagle's Medium supplemented with 1% calf 
serum and 100-200 I~Ci [35S]Translabel. The cells were labeled for 6-8 h 
at 37°C on an orbital shaker at 150 rpm. This gentle agitation prevented the 
oligodendrocytes from adhering to the surface of the flask and elaborating 
processes, thus obviating the need for chemical or enzymatic treatment of 
the cells to release them from the flask after labeling. 
After labeling, the media was removed and cells were pelleted as above 
and the pellet was washed with PBS. The cells were washed once more 
with DME containing 0.2% BSA (DME/BSA) and the final pellet was 
resuspended in DME/BSA. The suspension was then filtered through a20- 
~tM mesh stainless steel sieve (Celleetor, Bellco, Vineland, NJ) to remove 
cell aggregates. The filtered suspension was diluted with the same media 
to "02 x 105 cells/mi. 
All surfaces on which adhesion was to be measured were preincubated 
with DME/BSA for 30 rain before the addition of cells. The assay was begun 
by rapidly aliquoting 0.1 ml of cell suspension (,°2 × 104 cells) to wells 
containing 0.4 ml of DME/BSA and placing the plates at 37°C. The incuba- 
tion time was 30 min, unless otherwise noted. After incubation the plates 
were placed on an orbital shaker at 200 rpm for 10 s and the media was 
quickly aspirated. The adherent cells were disrupted with 0.5 ml of PBS 
containing 1% Triton X-100 and transferred to scintillation vials. 
Substrates, except for collagen, were applied to the plastic surface, (not 
tissue culture treated 24-well plates) in a final volume of 0.4 ml at a concen- 
tration of 7.5 I~g/ml in PBS containing 1mM Ca 2+ and 1 mM Mg 2+ and in- 
cubated at 37°C for 2 h. Substrate solutions were removed and the surfaces 
washed once with PBS. Collagens (Sigma Chemical Co., St. Louis, MO) 
were applied to the plastic surfaces following the method of Kleinman et 
al. (19). For protein substrates the amount of material retained on the plastic 
surface was estimated by extracting the protein retained on the surface and 
analyzing the sample on SDS-PAGE. A sample representing the total 
1. Abbreviations used in this paper: AGM, astroglial matrix; CHAPS, 
3-([3 -cholamidopropyl]dimethyl-ammonio)-l-propanesulfonate). 
amount of protein applied to each well was run on the same gel and the silver 
stained patterns were compared. For fibronectin and vitronectin, ,050% of 
the protein applied to a well could be recovered from the plastic surface. 
In experiments using antibodies to disrupt adhesion, wells were in- 
cubated for 1 h at 37"C in DME/BSA which contained a 1:200 dilution of 
the appropriate antisera. The media containing antibody was removed and 
the surface was washed once with PBS. In experiments u ing peptides to 
inhibit cell binding, 0.02 mi of a 25 x peptide stock in DME/BSA solution 
was aliquoted to each well immediately before addition of cells. 
b'tbronectin Purification. Fibronectin was purified from citrate-treated 
bovine plasma by gelatin affinity chromatography (50). The column was 
prepared by coupling elatin (Janssen, Beerse, Belgium) to Afligel-10 (Bio- 
Rad, Richmond, CA) in PBS at room temperature according to the Bio-Rad 
protocol. The coupled resin contained 25 mg gelatin/ml. The column was 
run at room temperature by applying 25 ml of filtered plasma to a 20-ml 
column. The bound material was washed extensively wtih PBS, followed 
by 2 column volumes of 1 M NaCI in PBS before afinal wash with 2 column 
volumes of 4 M urea. The material elnted with urea was dialyzed against 
PBS at room temperature. Roughly 90-95 % of the protein purified by this 
procedure migrated as a doublet of Mr 220,000. 
SDS-PAGE. Polyacrylamide slab gels were prepared with SDS using the 
buffer system of Laemmii (21). Samples to be analyzed were prepared in 
buffer containing 62.5 mM Tris, 3% SDS, 10% glycerol, 5% 13-mercapto- 
ethanol, pH 6.8. Samples were heated at 100°C for 5 rain and run on either 
8 or 15% gels with a 4.5% stacking layer. Gels were silver stained by the 
method of Merril (27). 
lmmunoblotting and Immunochemistry. Western blot analysis was car- 
ried out by electrophoretic ransfer to nylon membranes (Biotrace RP, Gel- 
man) according to the method of Towbin (47). The membranes were 
blocked overnight at room temperature in 1% nonfat dry milk in PBS con- 
taining 0.02% sodium azide, pH 7.5. Primary antibodies were diluted 1:200 
in 1% nonfat dry milk in PBS, and the membranes were incubated at 37°C 
for 1-2 h and washed with PBS. A horseradish peroxidase-conjugaled sec-
ondary antibody (Bio-Rad) was diluted 1:750 in 1% milk/PBS and the mem- 
branes were incubated at 37°C for 45 rain. After washing the membranes 
with PBS, antibody complexes were visualized with PBS containing 20% 
methanol, 0.5 mg/ml 4-chloro,l-naphthol, and 0.03 % H202. hnmunostain- 
ing was performed on oligodendrocyte cultures by fixing cells in freshly pre- 
pared 3.7 % paraformaldehyde in PBS for 15 min followed by 15 min in 3.7 % 
paraformaldehyde in PBS containing 0.2% Triton X-100. Fixed cells were 
incubated at 37°C for 2 h with a 1:100 dilution in PBS of antisera to either 
glial fibrillary acidic protein or to galactocerebroside or with nonimmune 
rabbit serum. The cells were washed with PBS several times over a period 
of 30 rain and incubated with a 1:200 dilution of FITC-conjugated goat 
anti-rabbit IgG (Cappel) at 37°C for 1 h. Both primary and secondary anti- 
bodies contained 1:25 dilution of normal goat serum to reduce the non- 
specific staining. The cells were washed thoroughly with PBS, mounted and 
visualized on a Nikon Diaphot-TMD inverted microscope. 
Synthetic Peptides. Peptides were prepared by Dr. Janice Young of the 
UCLA Peptide Synthesis Facility in the Department ofBiological Chemis- 
try. The peptides were synthesized on an Applied Biosystems, Inc. (Foster 
City, CA) 430A Peptide Synthesizer using version 1.3 software. 
Protein Determination. Protein values were estimated by the bicincho- 
ninic acid method using a kit supplied by Pierce (Rockford, IL) with BSA 
as standard (44). 
Results 
Oligodendrocyte Adhesion to Various Substrates 
A simple adhesion assay was used to test the ability of 
oligodendrocytes to adhere to various substrates. To deter- 
mine the viability of adherent cells and to ensure that cells 
bound in the assay were indeed oligodendrocytes, adhesion 
was carried out on AGM for 30 min as described inMaterials 
and Methods. Rather than extracting the adherent cells im- 
mediately for quantitation, though, culture media was added 
to the wells and the cells were grown for 2 d. As shown in 
Fig. 1, adherent cells display a morphology typical of cul- 
tured oligodendrocytes; the elaborate processes are particu- 
larly characteristic of this cell type. Immunofluorescence 
staining using anti-galactocerebroside, a specific marker for 
The Journal of Cell Biology, Volume 107, 1988 1542 
Figure L Oligodendrocytes bound in the adhe- 
sion assay. Oligodendrocytes were purified 
from mixed glial cultures, labeled in suspen- 
sion and washed as described in Materials and 
Methods. The cells were plated in DME/BSA 
on AGM and incubated for30 min. The 24-well 
plates were shaken and the media was aspirated 
as described in Materials and Methods. The 
adherent cells were maintained in culture for 
48 h in DME/FI2 containing 10% calf serum. 
Cells were viewed ona Nikon-TMD inverted 
microscope equipped with phase optics and a 
20x objective. The cells were photographed 
on Tri-X film before fixation for immunofluo- 
rescence. Bar, 75 ~tm. 
the oligodendrocyte, revealed positive staining in >80% of 
the cells. Only 7 % of cells present after 2 d in culture were 
stained with anti-glial fibrillary acidic protein, a specific 
marker for astrocytes. Most of those cells which were scored 
as negative for galactocerebroside nonetheless possessed a 
typical oligodendrocyte morphology and were weakly reac- 
tive with galactocerebroside antibody. We chose to im- 
munolabel the cells as soon as it was technically possible 
(i.e., when the cells had become attached well enough to 
withstand the numerous wash steps required) so that the 
population of cells closely reflected that used in adhesion ex- 
periments and was minimally effected by cell proliferation. 
Since the synthetic rate of galactocerebroside develops with 
time in culture (39), many oligodendrocytes are likely not 
detected by immunofluorescence after only 2 d in culture. 
The value of 80% is therefore a low estimate of the purity 
of oligodendrocytes used in these experiments. While fewer 
cells adhered to an untreated plastic surface, the percentage 
of galactocerebroside-positive cells was similar to the per- 
centage of galactocerebroside-positive cells that adhered to 
AGM (data not shown). 
As shown in Fig. 2, the initial rate of oligodendrocyte 
adhesion varied considerably depending on the nature of the 
substrate. If the incubation time was increased to 90 min, 
all surfaces, including untreated plastic, were essentially 
equally effective in promoting the adhesion of oligodendro- 
cytes (data not shown). 30 min was chosen as the incubation 
time for future assays, since the ffects of different surface 
treatments on the initial rate of adhesion were readily appar- 
ent at this time. Among surfaces examined for the ability to 
promote oligodendrocyte adhesion, AGM, bovine plasma 
fibronectin, rat plasma fibronectin, a d chondroitin sulfate 
all promoted the attachment ofoligodendrocytes o a similar 
extent, with a 2.5-3-fold greater adhesion than seen for un- 
treated plastic. Of all surface treatments examined, poly-L- 
lysine was most effective in the 30-min assay, increasing 
binding of cells nearly fivefold over the plastic level. Virtu- 
ally 100% of the radioactivity associated with trichloroacetic 
acid precipitable material adheres to poly-L-lysine in a 
15-30-min incubation. In a 90-min incubation essentially 
all of the radioactivity associated with TCA precipitable ma- 
terial adhered to all culture surfaces, indicating that given 
enough time all cells are competent to form stable adhesive 
interactions with a wide variety of substrates. 
An RGD-containing Peptide Inhibits Oligodendrocyte 
Adhesion to Fibronectin, Vitronectin, and AGM 
Fibronectin and vitronectin are among the best characterized 
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Figure 2. Time course of oligodendrocyte adhesion. 35S-labeled 
oligodendrocytes were incubated on surfaces treated with poly-L- 
lysine (e), bovine fibronectin (a), AGM ([]), prepared as described 
in Materials and Methods, or on untreated plastic (<3). After the in- 
dicated times the plates were shaken, the media aspirated, and the 
adherent cells extracted and counted as described in Materials and 
Methods. Each point represents he average of three wells and vari- 
ation between wells was less than 10%. 
adhesion proteins. Different cell surface receptors for each 
of these proteins have been purified and, in each case, shown 
to recognize a defined sequence of the fibronectin or vitro- 
nectin primary structure (1, 35, 36, 45). To examine the 
specificity of the oligodendrocyte's interaction with fibronec- 
tin and vitronectin we used, as an inhibitor of adhesion, a 
synthetic hexapeptide (GRGDSP) derived from the known 
sequence of the fibronectin cell-binding domain. At concen- 
,oo t 
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200 (..) 
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F N VT AGM UNTREATED 
SURFACE TREATMENT 
Figure 3. Inhibition ofoligodendrocyte adhesion by GRGDSP. Cells 
were incubated on bovine fibronectin (B-FN), vitronectin (VT), 
AGM, or untreated plastic. Hatched bars indicate the addition of 0.1 
mg/ml orGRGDSP in the incubation media. Values given are the 
average of 3 wells and the error bars indicate SD. 
Table L Inhibition of Oligodendrocyte Adhesion with 
Synthetic Peptides 
Cells Bound 
(percentage of control) 
Treatment AGM Plastic 
GRGDSP 53 100 
GRADSP 106 101 
SDGR 101 104 
VYPNGA 103 113 
The specificity of oligodendrocyte adhesion by GRGDSP was examined by 
testing several other peptides for inhibitory activity. All peptides were used at 
a final concentration f0.1 mg/ml. The percent cell binding to the plastic sur- 
face was determined by calculating the 35S radioactivity retained in wells con- 
taining peptide relative to wells which received no peptide. The percent cell 
binding to AGM was calculated by first subtracting the background level of 
35S radioactivity bound to untreated plastic from the values determined for 
binding to AGM. 
trations of 0.1 mg/ml, the peptide decreased binding of cells 
to fibronectin by 79 % and to vitronectin by 92 % (Fig. 3). In- 
creasing the concentration fpeptide above this level did not 
increase the specific inhibition. Interestingly, the peptide 
also inhibited oligodendrocyte binding to AGM, decreasing 
adhesion by 60 % at 0.1 mg/ml (Fig. 3). The RGD-containing 
hexapeptide had no effect on cell binding to plastic, poly-L- 
lysine or chondroitin sulfate (data not shown). 
The specificity of this inhibition was examined by screen- 
ing a group of peptides, both related and unrelated to 
GRGDSP. As shown in Table I, these peptides had no effect 
on adhesion of the oligodendrocyte to either AGM or to an 
untreated plastic surface. One of these peptides differed from 
the active peptide by the single substitution of alanine for 
glycine within the RGD sequence. Another inactive peptide, 
a tetramer with the sequence SDGR, represents he inverse 
sequence of the active region within the GRGDSP peptide, 
which has been shown to interfere with cell spreading of both 
baby hamster kidney cells and chick embryo fibroblasts on 
fibronectin, vitronectin, collagen, and laminin coated sur- 
faces (52). The peptide GRGES has been shown to inhibit 
the spreading of certain cell types on fibronectin coated sur- 
faces (15). This peptide, however, did not inhibit the adhe- 
sion of oligodendrocytes to either fibronectin or AGM (data 
not shown). 
RGD-dependent Component of AGM Is Produced by 
Mixed Glial Cells and Is Not Derived from Serum 
Since AGM is prepared from cells that have been grown in 
media containing calf serum, the RGD-dependent binding of 
oligodendrocytes to AGM might be explained by the pres- 
ence of serum-derived proteins in the AGM which can bind 
to cells in a RGD-inhibitable manner. Fibronectin and vi- 
tronectin are the most abundant and the best characterized 
proteins of this family. The binding of cells to both fibronec- 
tin and vitronectin is known to require divalent cations. As 
shown in Fig. 4, binding of oligodendrocytes to either 
fibronectin, vitronectin, or AGM, is diminished to the level 
of untreated plastic by addition of 2 mm EDTA, consistent 
with the notion that cells are binding to each of these proteins 
by a related mechanism. 
To further assess the role that serum-derived factors may 
play in the adhesive properties of AGM, tissue culture wells 
The Journal of Cell Biology, Volume 107, 1988 1544 
800" 
A 1 - 600  E o = ~_  
~. 400  
0 
QO 
200 
AGM FN VT UNTREATED 
SURFACE TREATMENT 
Figure 4. Effect of EDTA on oligodendrocyte adhesion. Cells were 
incubated on bovine fibronectin (FN), vitronectin (VT), AGM 
(AGM), or untreated plastic. Hatched bars indicate the addition of 
2 mM EDTA to the incubation media. Each bar represents he aver- 
age of three wells and the error bars indicate the SD. 
without cells were incubated with media containing 10 % se- 
rum at 37°C. The wells were maintained in serum-containing 
media for 7 d and the media was replenished on the same 
schedule as parallel plates containing mixed glial cells. All 
wells were then treated with water lysis and subsequent 
washes by the same procedure used to prepare AGM from 
E 
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Figure 5. Inhibition by GRGDSP of oligodendrocyte adhesion to 
serum-treated plastic and to AGM. Wells were plated with mixed 
glial cells or were "mock-treated" by the addition of DME/F12 con- 
taining 10% calf serum, but no cells. All wells were maintained on 
the same feeding schedule. After 13 d in culture, wells were treated 
with water lysis and washed resulting in AGM (from the wells 
which contained cells) and serum-treated plastic (from those wells 
which contained no cells). These surfaces were then used to com- 
pare adhesion in the presence (hatched bars) and absence (open 
bars) of 0.1 mg/ml of GRGDSP. 
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Figure 6. Inhibition of oligodendrocyte adhesion by antibodies to 
fibronectin and vitronectin. AGM (AGM), vitronectin-(VT), and 
fibronectin-(FN) coated surfaces were preincubated with antibodies 
to fibmnectin (solid bars), vitronectin (hatched bars), or with 
nonimmune rabbit serum (open bars), as described in Materials 
and Methods. The antibody treated surfaces were washed with PBS 
before measuring oligodendrocyte adhesion. Each bar represents 
the average of three wells and the error bars indicate SD. 
mixed cells. These surfaces were then used to compare 
RGD-dependent adhesion. As shown in Fig. 5, the mock- 
treated surface exhibited only 16% of the RGD-dependent 
adhesion of AGM. 
Thus it appears that serum-derived factors are insufficient 
to account for the behavior of AGM. It is conceivable, how- 
ever, that serum proteins uch as fibronectin and/or vitronec- 
tin could combine with constituents of the AGM to show 
adhesion beyond that seen for either protein alone. However, 
if this were the case, antibodies which specifically inhibit 
adhesion to purified serum proteins might be expected to in- 
hibit adhesion to the AGM as well. As shown in Fig. 6, 
pretreatment of wells with antibodies to fibronectin inhibited 
adhesion of cells to fibronectin-coated plastic, but were 
ineffective against either vitronectin, or AGM. Similarly, an- 
tibodies to vitronectin inhibited adhesion to vitronectin- 
coated surfaces but were ineffective against either fibronectin 
or AGM. 
The antibodies against mouse fibronectin are equally 
effective in inhibiting adhesion to both rat and bovine 
fibronectin excluding the possibility that fibronectin secreted 
by the glial cells is the active adhesion component of the 
AGM. 
In a separate xperiment, surfaces pretreated with anti- 
body to either fibronectin, vitronectin or both were tested for 
RGD-inhibitable adhesion. As shown in Fig. 7, fibronectin 
antibodies inhibit the binding of oligodendrocytes to fibro- 
nectin-coated surfaces to the background value of untreated 
plastic and addition of RGD-containing peptide caused no 
further inhibition. The same is true of vitronectin-coated 
surfaces; antibodies to vitronectin decrease binding to back- 
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Figure 7. GRGDSP inhibition of oligodendrocyte adhesion to sur- 
faces pretreated with antibodies to fibronectin and vitronectin. 
Fibronectin-(FN) coated surfaces were preincubated with non- 
immune serum, or anti-fibronectin (anti-FN); vitronectin-(I/T) 
coated surfaces were preincubated with nonimmune serum, or anti- 
vitronectin (anti-fiT); AGM was preincubated with nonimmune s - 
rum, or with both anti-FN and anti-VT. Oligodendrocyte adhesion 
was measured inthe presence and absence of 0.1 mg/ml GRGDSP. 
Each bar epresents he average of 3 wells and the error bars indi- 
cate SD. 
ground levels and no RGD-inhibitable adhesion is evident on 
antibody treated surfaces. When AGM is treated with anti- 
bodies to both vitronectin a d fibronectin, cell binding is di- 
minished by 18%. However, 44% of the cells which bind to 
AGM treated with both antibodies are still inhibited by 0.1 
mg/ml of RGD-containing hexapeptide, indicating that the 
RGD-inhibitable behavior of the AGM is imparted largely by 
a component(s) other than fibronectin or vitronectin. 
To estimate the amount of fibronectin or vitronectin that 
would be needed to account for the properties of AGM, we 
carried out titration curves, applying variable amounts of 
purified proteins to the plastic wells and measuring adhesion 
of oligodendrocytes to these surfaces. Maximal adhesion oc- 
Figure & Western blot analysis of AGM using antibodies to 
fibronectin and vitronectin. AGM was extracted from the surface 
of flasks in SDS-PAGE sample buffer asdescribed in Materials and 
Methods. Approximately 0.75-1.0 ~tg of AGM extract was run per 
lane which is the amount of material extracted per 1 cm 2 culture 
surface. In A, a 15% gel was run with AGM extract (lane a), 0.01, 
0.10, and 1,0 Ixg vitronectin (lanes b, c, and d). In B, a 8% gel with 
AGM extract (lane a), 0.01, 0.1 and 1.0 Ixg bovine fibronectin (lane 
b, c, and ). The gels were transferred to nylon membranes and 
processed with anti-vitronectin a tibodies (A) or anti-fibronectin 
antibodies (B). 
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Figure 9. Effect of pronase digestion of AGM on oligodendrocyte 
adhesion. AGM and untreated plastic surfaces were incubated with 
PBS containing 10 ~tg/ml pronase B for 1 h at 37°C. The surfaces 
were washed with PBS and used to compare adhesion of oligoden- 
drocytes in the presence (hatched bars) and absence (open bars) of
0.1 mg/ml GRGDSP. 
curred at >1.0 ~tg/well fibronectin and at >0.5 ~tg/well 
vitronectin. The material extracted from AGM was directly 
analyzed on SDS-PAGE for the presence of these serum pro- 
teins. Neither protein is detected by western blotting (Fig. 8). 
In other experiments using more concentrated AGM we were 
able to detect 20 ng/well of fibronectin. This amount is less 
than 5 % of what would be required to explain the RGD- 
inhibitable properties of AGM. 
The results summarized above suggest that the component 
of AGM responsible for its RGD-inhibitable behavior is not 
derived from serum. In particular, they show that the active 
component is neither fibronectin nor vitronectin. Three 
other proteins which bind to cells via RGD-dependent mech- 
anisms, thrombospondin (22), Type I collagen (8) and tenas- 
cin (7, 9), were also considered as the AGM active com- 
ponent. Antibodies to human thrombospondin and chick 
tenascin were ineffective in inhibiting the adhesion of 
oligodendrocytes to AGM and neither tenascin nor throm- 
bospondin were detected in AGM extracts by western blot 
(data not shown). Plastic surfaces coated with either type IV 
or type I collagen did not promote adhesion above the level 
for untreated plastic. Antibodies to type IV collagen, which 
contains an RGD-sequence (43), did not inhibit the binding 
of cells to AGM (data not shown). 
The chemical nature of the active factor(s) in AGM was 
probed by digestion of AGM using protease and glycosi- 
dases. As shown in Fig. 9, digestion of AGM with pronase 
B reduces the binding of cells to the level of untreated plastic. 
The pronase digested AGM shows essentially no RGD inhi- 
bition. In contrast, digestion of AGM with heparinase and 
chondroitinase ABC (Miles, Lisle, IL) had little or no effect 
on cell adhesion (data not shown). 
Discussion 
The use of cells in primary culture to study the differentiated 
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properties which typify those cells in vivo, often requires the 
use of a specific substratum (11, 13, 38, 41). Schwann cells, 
the counterpart ofthe oligodendrocyte in the peripheral ner- 
vous system, when kept in culture under appropriate condi- 
tions, produce an extracellular matrix which is similar to the 
matrix formed in peripheral nerve endoneurium. In these 
cultures, basement membrane components have been shown 
to induce normal Schwann cell differentiation (6, 26). Our 
interest in the substratum produced by mixed glial cultures 
stems from the observations that oligodendrocytes plated on 
AGM, rather than plastic or poly-L-lysine, tend to more rap- 
idly extend processes and develop morphologically. In ad- 
dition, cells plated on AGM show a twofold higher rate of 
incorporation of [3H]thymidine into trichloroacetic a id pre- 
cipitable material than cells grown either on plastic or poly- 
L-lysine (Bullock, P. N., and L. H. Rome, unpublished ob- 
servations). As a first step in quantifying the role that the 
AGM plays in development of oligodendrocytes in culture, 
we have begun to characterize the initial adhesive interaction 
between oligodendrocytes and components of this surface. 
The results presented here show that oligodendrocytes, 
like many cell types, bind to fibronectin and vitronectin in 
an RGD-dependent manner. More interestingly, oligoden- 
drocytes bind to a protein component present in an extracel- 
lular matrix produced by cultures of mixed glial cells. This 
interaction is also inhibited by an RGD-containing hexapep- 
tide. The AGM interaction is not inhibited by antibodies to 
either vitronectin or fibronectin even though the same anti- 
body treatment prevented oligodendrocyte adhesion to a sur- 
face coated with the purified proteins. Furthermore, the 
AGM component does not appear to be derived from serum. 
Cultures of astrocytes from neonatal rat cerebral cortex 
have been reported to synthesize fibronectin (34). These cul- 
tures synthesize and secrete fibronectin i  amounts compara- 
ble to fibroblasts, but the form of the protein produced oes 
not assemble into a matrix. Fibronectin has also been im- 
munolocalized to the surface of astrocyte cultures which 
were derived from various brain regions. However, astro- 
cytes from neonatal cerebral cortex, as used in our study to 
form the AGM, were negative when stained for cell surface 
fibronectin (23). Since our fibronectin antibodies recognize 
rat as well as bovine fibronectin, it is unlikely that fibronectin 
secreted by the mixed glial cells, or derived from serum, is 
the active component of the AGM. 
It was possible that he RGD-dependent behavior of AGM 
could be imparted by fibronectin derived from either the se- 
rum or the mixed glial cells which, though interactions with 
other products of the glial cultures, were not recognized by 
the antibodies we used. For example, the binding of pro- 
teoglycans to a site distinct from the cell-binding site has 
been shown to inhibit the cell-binding characteristics of
fibronectin and of type I collagen (41). Presumably the pro- 
teoglycan exerts this effect indirectly by obscuring the cell- 
binding domain. A similar interaction with proteoglycans 
secreted by the glial cells might result in the 'masking' of 
fibronectin antigenic sites from antibodies. However, since 
we could not detect an appreciable vel of either fibronectin 
or vitronectin i  AGM extracts by western blot, it is unlikely 
that these proteins are components of AGM. 
Thrombospondin is another serum protein which binds to 
cells in an RGD-dependent manner (22). That this protein 
might be a component ofthe AGM is suggested by the report 
that cultures of human astrocytes synthesize thrombospondin 
(2). However, antibodies to human thrombospondin had no 
effect on the ability of oligodendrocytes to adhere to the 
AGM. Additionally, we were unable to demonstrate i spres- 
ence in extracts of AGM by western blot. 
The extracellular p otein tenascin (7, 9), previously known 
as chick myotendinous antigen, is apparently identical to 
several independently isolated extraceUular p oteins, includ- 
ing cytotactin. Cell binding to this protein is inhibited by 
RGD-containing peptides. Cytotactin has been shown to be 
produced by glial cells and has been implicated in neu- 
ron-glia interactions (12). While we did see material which 
reacted with tenascin antibodies in extracts of mixed glial 
cultures, antibodies to tenascin were ineffective in inhibiting 
adhesion to AGM and the protein was not detected in AGM 
by western blot. 
The chemical basis of the oligodendrocyte/neuron interac- 
tion has been the subject of much speculation. Several mole- 
cules with cell adhesive properties have been implicated as 
mediators of this interaction. The neural cell adhesion mole- 
cule, NCAM, is widely distributed among neuronal types 
and is a component ofoligodendrocytes both in vivo (24) and 
in vitro (29). In contrast to the mechanism of fibronectin 
binding to its receptor, NCAM mediated cell-cell interac- 
tions are homophillic and Ca 2÷ independent. The myelin as- 
sociated glycoprotein, MAG, has been suggested to play a 
role in the interaction on the basis of its periaxonal localiza- 
tion within myelin and on its adhesive properties een with 
in vitro assays (33). MAG, NCAM, and cytotactin are mem- 
bers of a group of adhesion proteins which share a common 
carbohydrate epitope which is itself implicated in the adhe- 
sive properties of these proteins (20). Interestingly, cytotac- 
tin has been shown bind to cells in an RGD-dependent man- 
ner and, while MAG has not been shown to have such 
binding properties, it has been reported to have an RGD re- 
gion in a proposed extracellular domain. The precise role 
that these proteins play in oligodendrocyte function remains 
to be determined but the potential overlap between these two 
classes of adhesive interactions i intriguing. 
Oligodendrocytes were able to adhere in an RGD-depen- 
dent manner to at least three different ligands; fibronectin, 
vitronectin, and a component in AGM. Several cell surface 
receptors which recognize RGD sequences have been iso- 
lated (1, 8, 10, 14, 17, 30, 35-37). Fibroblasts bind to both 
vitronectin and fibronectin via distinct receptor complexes, 
which show exclusive binding specificities. There is prece- 
dent, however, for a single receptor complex binding to sev- 
eral different proteins in an RGD-dependent manner. The 
glycoprotein IIb/IIIa complex of platelets binds to at least 
four different proteins in an RGD-dependent manner (9, 37). 
Integrin, previously called CSAT antigen, binds to fibronec- 
tin, vitronectin and to laminin (14). The binding of this 
receptor complex to all three of these proteins is inhibited by 
RGD-containing peptides. Our preliminary attempts to pu- 
rify an oligodendrocyte cell surface protein by chromatogra- 
phy of detergent extracts of these cells on immobilized 
GRGDSP hexapeptide have so far been unsuccessful. How- 
ever, affinity chromatography using an immobilized peptide 
has been generally less effective than chromatography with 
the intact protein or proteolytic fragments of the parent pro- 
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tein. For example, while both the vitronectin and fibronectin 
receptors from osteosarcoma cells can be affinity purified 
using the parent protein as affinity support, only the 
vitronectin receptor can be isolated using a peptide affinity 
column (35, 36). 
The adhesive component of the AGM can be solubilized 
using detergents and chaotropic agents. We have not yet been 
able to reconstitute the adhesive activity of these extracts. A 
major obstacle to these studies has been the insolubility of 
the AGM under physiological conditions. For example, a 
buffer containing 4 M urea and 1% CHAPS completely re- 
moves the activity from the culture surface. Dialysis of this 
extract against PBS at room temperature results in the irre- 
versible precipitation of most of the protein, and what re- 
mains in solution is inactive in promoting adhesion. 
Recent work on the biology of the oligodendrocyte has 
suggested that nonspecific adhesion may play a role in the 
phenotypic development of these cells in culture (48, 53). 
Using a system in which mature oligodendrocytes can be 
maintained either floating or attached to a poly-L-lysine 
surface, it has been demonstrated that attached cells show 
increased levels of synthesis of the major myelin proteins 
(proteolipid protein and myelin basic protein), as well as in- 
creased phosphorylation of myelin basic protein. With our 
observation of a specific and easily inhibitable adhesive in- 
teraction as a starting point, we have begun to examine the 
contribution that this RGD-dependent interaction makes to 
development of the myelin-like properties of neonatal rat 
oligodendrocytes in culture (5). 
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